Global Surgical Staplers Market is expected to reach USD 3,692.2 million by 2024 from USD 2,005.0 million in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Manual surgical staplers market has the largest market segment in surgical staplers market.
Access Full Report:- http://databridgemarketresearch.com/reports/global-surgical-staplers-market/ The global surgical staplers market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Medtronic dominated the surgical staplers market accounting for the highest market share in 2016, followed by Ethicon. U.S., LLC. Other players in this market include Cardica Inc., Smith and Nephew Plc, CONMED Corporation, Purple Surgical Inc., Welfare Medical Ltd, Reach Surgical., Grena Ltd., B.Braun Melsungen AG, Frankenman International Limited, Zimmer Biomet, Stryker, Meril Life Sciences Pvt. Ltd., and Touchstone International Medical Science Co. Ltd. among others held 11.9% of the global surgical staplers market in 2016.
Founded in 1949 and headquartered in Minneapolis, U.S. Medtronic is a global healthcare solutions company and it is the world’s largest standalone medical technology development company. The company operates in four business segments, cardiac and vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group.
In February 2014, Covidien plc., subsidiary of Medtronic received 510(k) clearance for Endo GIA Reinforced Reload surgical stapler device with tri-staple technology.
In August 2012, Covidien plc., subsidiary of Medtronic received 510(k) clearance for iDrive Ultra Powered Stapling System. It is fully powered, reusable, battery-operated endoscopic surgical stapler which improves staple line strength, hemostasis, and is leak resistance.
Ethicon. U.S., LLC:
Founded in 1886 and headquartered at New Brunswick, New Jersey, U.S., Ethicon US, LLC., is a subsidiary of Johnson & Johnson Services, Inc., is engaged in the development and marketing of healthcare products. The company operates through three business segments- Consumer, Pharmaceutical, and Medical Devices.
In May 2017, Ethicon US, LLC launched a new product ECHELON FLEX GST (Gripping Surface Technology) which is used in thoracic and colorectal surgery. The product is designed to enhance the stapling performance and is suited for facing the challenges in thoracic and colorectal procedures which involves diseased, thick, and thin tissues.
In April 2017, Ethicon US, LLC received 510(K) approval from U.S. Food and Drug Administration for ECHELON CIRCULAR Powered Stapler to reduce complications in colorectal, gastric and thoracic cancer surgeries.